CMR Naviscan

CMR Naviscan is a medical device company focused on organ-specific molecular imaging for breast cancer detection and diagnosis. The company markets dedicated breast imaging systems, including molecular breast imaging and positron emission mammography products, designed to improve detection in women with dense breasts and in cases where conventional imaging is equivocal. Its portfolio includes commercially marketed products such as lumaGEM, Solo II and Stereo Navigator for imaging and biopsy guidance. CMR Naviscan operates from Carlsbad, California as part of the Compañía Mexicana de Radiología family of companies and appears to function as an operating subsidiary rather than an independent drug developer.